Literature DB >> 11017956

A sensitive assay of tumor necrosis factor alpha in sera from Duchenne muscular dystrophy patients.

K Saito1, D Kobayashi, M Komatsu, T Yajima, A Yagihashi, Y Ishikawa, R Minami, N Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11017956

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  9 in total

1.  A dendrimer-based immunosensor for improved capture and detection of tumor necrosis factor-α cytokine.

Authors:  Admira Bosnjakovic; Manoj K Mishra; Hye Jung Han; Roberto Romero; Rangaramanujam M Kannan
Journal:  Anal Chim Acta       Date:  2012-01-18       Impact factor: 6.558

2.  Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Justin M Percival; Nicholas P Whitehead; Marvin E Adams; Candace M Adamo; Joseph A Beavo; Stanley C Froehner
Journal:  J Pathol       Date:  2012-07-18       Impact factor: 7.996

3.  The chondrogenic response to exercise in the proximal femur of normal and mdx mice.

Authors:  David J Nye; Jeffrey M Costas; Jessica B Henley; Jin-Kwang Kim; Jeffrey H Plochocki
Journal:  BMC Musculoskelet Disord       Date:  2010-09-03       Impact factor: 2.362

4.  Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice.

Authors:  Felicity J Waters; Thea Shavlakadze; Matthew J McIldowie; Matthew J Piggott; Miranda D Grounds
Journal:  Mol Cell Biochem       Date:  2009-10-27       Impact factor: 3.396

5.  Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.

Authors:  S Lecompte; M Abou-Samra; R Boursereau; L Noel; S M Brichard
Journal:  Cell Mol Life Sci       Date:  2017-02-10       Impact factor: 9.261

6.  Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.

Authors:  Gustav J Strijkers; Ericky C A Araujo; Noura Azzabou; David Bendahan; Andrew Blamire; Jedrek Burakiewicz; Pierre G Carlier; Bruce Damon; Xeni Deligianni; Martijn Froeling; Arend Heerschap; Kieren G Hollingsworth; Melissa T Hooijmans; Dimitrios C Karampinos; George Loudos; Guillaume Madelin; Benjamin Marty; Armin M Nagel; Aart J Nederveen; Jules L Nelissen; Francesco Santini; Olivier Scheidegger; Fritz Schick; Christopher Sinclair; Ralph Sinkus; Paulo L de Sousa; Volker Straub; Glenn Walter; Hermien E Kan
Journal:  J Neuromuscul Dis       Date:  2019

7.  Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status.

Authors:  Oriana Del Rocío Cruz-Guzmán; Maricela Rodríguez-Cruz; Rosa Elena Escobar Cedillo
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

Review 8.  Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.

Authors:  Boel De Paepe; Jan L De Bleecker
Journal:  Mediators Inflamm       Date:  2013-11-05       Impact factor: 4.711

Review 9.  Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress.

Authors:  Miranda D Grounds; Jessica R Terrill; Basma A Al-Mshhdani; Marisa N Duong; Hannah G Radley-Crabb; Peter G Arthur
Journal:  Dis Model Mech       Date:  2020-03-02       Impact factor: 5.758
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.